Enhancing go-to-market strategies with real-world data
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Understanding re-identification risk in PPRL: key takeaways from our expert webinar
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Honoring MOM: How far we've come
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Three key elements to improve physician outreach
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
Using Real-World Data to Power Government Health Messaging
The COVID-19 pandemic illustrated how vital government communications can be for effective public...
Contextualizing clinical trials with real-world data
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
A modern method for managing Medicaid
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
Accelerating the path to regulatory submission with RWD
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
Following the data crumbs in a cookieless world
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
Clinical research alternatives for medical claims
With recent disruptions in the availability of real-world data (RWD) for clinical research,...